BioGaia AB (publ) (OTCMKTS:BIOGY) Short Interest Up 200.0% in August

BioGaia AB (publ) (OTCMKTS:BIOGY – Get Free Report) saw a large increase in short interest in the month of August. As of August 31st, there was short interest totaling 393 shares, an increase of 200.0% from the August 15th total of 131 shares. Based on an average daily volume of 117 shares, the short-interest ratio is presently 3.4 days.

BioGaia AB (publ) Price Performance

BIOGY opened at $12.45 on Monday. BioGaia AB has a one year low of $9.64 and a one year high of $12.45. The business has a 50 day simple moving average of $11.90 and a two-hundred day simple moving average of $11.32.

About BioGaia AB (publ)

(Get Free Report)

BioGaia AB (publ) is a Sweden-based biotechnology company specializing in the development, manufacturing and marketing of probiotic products for human and animal health. The company’s core research centers on select Lactobacillus reuteri strains, supported by extensive clinical studies to promote digestive wellness, immune support and oral health. BioGaia collaborates with academic institutions and healthcare organizations to translate scientific findings into consumer and medical applications.

BioGaia’s product portfolio includes probiotic drops, chewable tablets and oral health lozenges designed for infants, children and adults.

See Also

• Five stocks we like better than BioGaia AB (publ)
• Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
• 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
• Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
• As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits

Receive News & Ratings for BioGaia AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioGaia AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.